Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Residual cognitive and speech effects after single-dose zolpidem or temazepam
ACTRN12616000033448Phase 4Active, not recruiting
- Sponsor
- Monash University
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of zolpidem and temazepam (4 arms), sponsored by Monash University. Primary endpoints: Composite speech characteristics at baseline, Composite speech characteristics after nocturnal awakening and 1 more. Started Jul 2014; status: active, not recruiting.
02
Drugs
zolpidemtemazepam
Beyond the preview
Go deeper on ACTRN12616000033448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000033448.